New Poll Finds Voters Deeply Frustrated by Health Costs, Transparency

October 30, 2018 by TWN Staff
In a June 2013 file image a doctor draws blood from a patient during an exam in Los Angeles. (Glenn Koenig/Los Angeles Times/TNS)

In the final stretch before Election Day, a new survey by Ipsos and Consumers for Quality Care (CQC) found that voters are deeply frustrated by unpredictable costs and the lack of transparency in health care. Health care consistently factors into the top issues facing voters in a wide variety of issue-based polls.

The top item Americans reported as most frustrating about health care are hospital fees and unexpected bills (74 percent).

“Information is power, and consumers are hungry for a better understanding about how consumer costs are determined in the health care realm,” said CQC Board Member Scott Mulhauser. “The consensus on prioritizing transparency and predictability transcends political parties. Consumers and families are particularly eager for more clarity…so they can make better decisions and avoid getting hit with surprise bills and fees.”

In the survey, more than 60 percent of respondents said it’s too difficult to know how much they are going to have to pay for health care. Approximately 3 in 4 voters also want more clarity about out-of-pocket hospital and prescription costs, and what treatments, providers and medicines are covered by their insurance.

Notably, the survey also found that voters don’t think fixing health care is a problem solely for lawmakers to solve. They believe the private health care industry has even more power than policymakers to improve the system, and they want all the players in the health care ecosystem to step up to the plate.

More than 75 percent of voters believe hospitals can have the largest impact on improving health care, followed closely by insurance and pharmaceutical companies (72 percent), and medical professionals (72 percent). Voters also believe that Congress (69 percent), state policymakers (67 percent) and President Trump (57 percent) can have a significant impact improving U.S. health care.

“Across party lines, Americans say private sector health care entities can have the largest impact on improving U.S. health care,” Mulhauser continued. “This research makes clear that Democrats and Republicans agree on a great deal more than you’d think about the problems plaguing the system, and ultimately we want innovative solutions from policymakers and the private sector that shine a bright light on costs,patient assistance programs, and other ways to save money.”

The changes a strong majority of Americans want included:

  • Informing customers at the point-of-sale if there is a way to save money on a prescription (80 percent);
  • Requiring increased transparency from hospitals, health insurance, and pharmaceutical companies about cost and access to health care (77 percent);
  • Requiring pharmaceutical companies to provide more information about drug costs and financial assistance that may be available to patients (75 percent); and
  • Requiring hospitals and clinics to show how much they are marking up the costs for standard treatments (69 percent).

This is the second poll Ipsos has conducted on behalf of Consumers for Quality Care. The first CQC-Ipsos survey results were released in April 2018 and found that Americans fear health care costs even more than they worry about costs associated with retirement, college, housing or child care.

The new Ipsos poll was conducted October 4-11, 2018. The survey sample included more than 1,700 adults age 18+ from the continental U.S., Alaska and Hawaii, with oversamples of 250 African Americans and 250 Hispanics to ensure fuller demographic representation. The interview was conducted online in both English and Spanish.

More information can be found at www.consumers4qualitycare.org/research.

 

In The News

Health

Voting

Health

FDA Clears Single-Shot Vaccine for Use
Health
FDA Clears Single-Shot Vaccine for Use
March 1, 2021
by Daniel Mollenkamp

WASHINGTON - On Saturday, the Food and Drug Administration gave emergency authorization to a third coronavirus vaccine. This vaccine, unlike the Pfizer and Moderna vaccines which received emergency authorizations in December, is a single shot vaccine.  Placebo-controlled, randomized studies of 43,783 participants across eight countries, including... Read More

House Passes $1.9 Trillion COVID Relief Package
Congress
House Passes $1.9 Trillion COVID Relief Package
February 27, 2021
by Dan McCue

WASHINGTON – The House passed a $1.9 trillion coronavirus relief package in the wee hours of Saturday morning, helping President Joe Biden clear the first hurdle in passing an economic stimulus bill that includes $1,400 in direct payments to U.S. households, an extension of federal supplements... Read More

FDA Relaxes Vaccine Storage Rules to Speed Up Rollout
Health
FDA Relaxes Vaccine Storage Rules to Speed Up Rollout
February 26, 2021
by Daniel Mollenkamp

WASHINGTON - The Food and Drug Administration has relaxed the rules around storage and transportation for some coronavirus vaccines in order to speed up the vaccine rollout. Frozen vials of Pfizer-BioNTech's coronavirus vaccine will be allowed to be kept at "conventional temperatures" found in pharmaceutical freezers... Read More

Fauci: Whatever Vaccine is Available, Take It
Health
Fauci: Whatever Vaccine is Available, Take It

WASHINGTON — Dr. Anthony Fauci says if a coronavirus vaccine is available, regardless of which one, take it. The top U.S. infectious disease expert told NBC on Thursday a third vaccine becoming available “is nothing but good news” and would help control of the pandemic. U.S.... Read More

Biden Tells Virtual Gathering Face Mask Distribution Coming
White House
Biden Tells Virtual Gathering Face Mask Distribution Coming
February 24, 2021
by TWN Staff

WASHINGTON — President Joe Biden said during a virtual meeting with essential workers on Wednesday that the administration plans to distribute millions of cloth face masks beginning early next month. According to a statement from the White House, the reusable, American-made masks will be available beginning in March... Read More

FDA Says J&J 1-Dose Shot Prevents COVID; Final Decision Soon
Health
FDA Says J&J 1-Dose Shot Prevents COVID; Final Decision Soon

WASHINGTON (AP) — Johnson & Johnson's single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.  The Food and Drug Administration's scientists confirmed that overall the... Read More

News From The Well
scroll top